Stock A095700 GENEXINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Genexine, Inc.

Equities

A095700

KR7095700001

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
7,510 KRW +1.21% Intraday chart for Genexine, Inc. +3.44% -24.14%
2023 Genexine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Genexine, Inc. and PT Kalbe Genexine Biologics Receives the First Market Approval for Novel Long-Acting Erythropoietin, Efepoetin Alfa, from the Indonesian Food and Drug Authority CI

Business Summary

Genexine Inc is a Korea-based company mainly engaged in the research and development of bio pharmaceuticals. The Company operates its business through two segments. The New Drug Development segment engages in human growth hormone, neutropenia treatment, anemia treatment, anticancer immunotherapy, hyFc platform, and other technology transfers. In addition, this segment sells the technical property rights of follicle-stimulating hormone. It also engages in cell line construction and sample production, project development, animal testing, human growth hormone development, and government agency research. The Medical Consumables segment produces and sells medical consumables such as medicine bags.

Number of employees: 98

Sales per Business

KRW in Million2022Weight2023Weight Delta
Services
86.4 %
6,008 37.2 % 3,825 86.4 % -36.33%
Technology Transfer
11.8 %
10,060 62.3 % 524 11.8 % -94.79%
Other
1.7 %
72 0.4 % 77 1.7 % +7.49%

Sales per region

KRW in Million2022Weight2023Weight Delta
United States
60.5 %
4,486 27.8 % 2,677 60.5 % -40.31%
South Korea
39.0 %
1,700 10.5 % 1,724 39.0 % +1.43%
Asia
0.6 %
9,954 61.7 % 25 0.6 % -99.75%

Managers

Managers TitleAgeSince
Young-Chul Sung FOU
 Founder 68 99-06-07
Jung-Won Woo CEO
 Chief Executive Officer 64 21-08-31
Yong-MIn Won DFI
 Director of Finance/CFO 60 -
Yu-Seok Seo BRD
 Director/Board Member 54 -
Seong-Gi Baek AUD
 Comptroller/Controller/Auditor 75 -
Gwang-Ho Kim HRO
 Human Resources Officer 61 -
Kyu-Don Kim PRN
 Corporate Officer/Principal 66 -

Members of the board

Members of the board TitleAgeSince
Young-Jin Kim BRD
 Director/Board Member 67 15-03-19
Peter N. Laivins BRD
 Director/Board Member 66 -
Young-Chul Sung FOU
 Founder 68 99-06-07
Yu-Seok Seo BRD
 Director/Board Member 54 -
Hyi-Jeong Ji BRD
 Director/Board Member 64 -
Jin-Geon Bae BRD
 Director/Board Member 72 -
Mi-Jung Ahn BRD
 Director/Board Member 62 -
Seong-Gi Baek AUD
 Comptroller/Controller/Auditor 75 -
Tae-Yong Lee BRD
 Director/Board Member 64 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 41,510,594 32,961,092 ( 79.40 %) 60,816 ( 0.1465 %) 79.40 %

Shareholders

NameEquities%Valuation
HANDOK INC.
14.57 %
6,048,534 14.57 % 39 M ₩
Young-Chul Sung
5.866 %
2,435,174 5.866 % 16 M ₩
YUHAN CORPORATION
1.184 %
491,570 1.184 % 3 M ₩
DONGWHA PHARM.CO.,LTD
0.2168 %
90,013 0.2168 % 581 700 ₩
KB Asset Management Co. Ltd.
0.0423 %
17,561 0.0423 % 113 486 ₩
CRUX Asset Management Ltd.
0.0342 %
14,205 0.0342 % 91 798 ₩
Dimensional Fund Advisors Ltd.
0.0194 %
8,072 0.0194 % 52 164 ₩
Korea Investment Management Co., Ltd.
0.0163 %
6,755 0.0163 % 43 654 ₩
Genexine, Inc. Esoa
0.0128 %
5,293 0.0128 % 34 205 ₩
DFA Australia Ltd.
0.0126 %
5,212 0.0126 % 33 682 ₩

Holdings

NameEquities%Valuation
TOOLGEN INCORPORATED
14.10%
 1,118,347 14.10% 56,405,397 $
GI INNOVATION, INC.
0.69%
 303,030 0.69% 2,973,464 $
GENNBIO INC.
2.49%
 1,844,723 2.49% 542,607 $

Company contact information

Genexine, Inc.

4/F, Korea Bio Park Bldg. B 700 Daewangpangyo-ro

13488, Seongnam-si

+

http://www.genexine.com
address Genexine, Inc.(A095700)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
GENEXINE, INC. Stock Genexine, Inc.
-24.14% 233M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.65% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+6.75% 101B
ARGENX SE Stock argenx SE
+6.58% 23.07B
BIONTECH SE Stock BioNTech SE
-12.60% 22.23B
GENMAB A/S Stock Genmab A/S
-6.17% 18.05B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.17% 16.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.12% 14.07B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.47% 12.35B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. A095700 Stock
  4. Company Genexine, Inc.